Intrepid Potash, Inc. (IPI)

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell

AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell

3 Fertilizer Stocks to Keep an Eye on Amid Industry Headwinds

Potash producers slide after Trump touts Belarus purchase deal

Has Intrepid Potash (IPI) Outpaced Other Basic Materials Stocks This Year?

Intrepid Potash Inc (IPI) Shares Surge 3.4% -- What GF Score of 69 Tells Investors

Are Basic Materials Stocks Lagging Intrepid Potash (IPI) This Year?

5 High-Efficient Stocks With Strong Financial Performance

BlackRock Inc. Acquires Shares of 1,155,559 Intrepid Potash, Inc $IPI

Connor Clark & Lunn Investment Management Ltd. Purchases New Stake in Intrepid Potash, Inc $IPI

Intrepid Potash: Seeing This As A Cyclical Play Is A Mistake

What Makes Intrepid Potash (IPI) a Strong Momentum Stock: Buy Now?

Intrepid Potash Q2 Earnings Call Highlights

Intrepid Potash, Inc. (IPI) Q2 2026 Earnings Call Transcript

Intrepid Potash (IPI) Tops Q2 Earnings and Revenue Estimates

Intrepid Announces Second Quarter 2026 Results

Analysts Estimate Intrepid Potash (IPI) to Report a Decline in Earnings: What to Look Out for

Caxton Associates LLP Takes $751,000 Position in Intrepid Potash, Inc $IPI